Linuo Medicine Pack: Announcement on the passive dilution of the company’s controlling shareholder’s shareholding ratio reaching an integral multiple of 1%
Securities code: 301188 Securities abbreviation: Linuo Medicine Pack Announcement number: 2026-031 Bond code: 123221 Bond abbreviation: Linuo Convertible Bonds
Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Announcement on the passive dilution of the company’s controlling shareholder’s shareholding ratio to an integral multiple of 1%
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Special tips:
This change in equity is mainly due to the increase in the total share capital of Shandong Linuo Pharmaceutical Packaging Co., Ltd. (hereinafter referred to as the "Company") due to the conversion of "Lino Convertible Bonds", which has passively diluted the proportion of the company's shares held by the company's controlling shareholder Linuo Investment Holding Group Co., Ltd. (hereinafter referred to as "Lino Investment") to an integral multiple of 1%. It does not involve a change in the number of shares held or a tender offer.
This change in equity will not lead to changes in the company’s controlling shareholders and actual controllers, nor will it affect the company’s governance structure and ongoing operations.
1. Basic situation of this equity change
According to the China Securities Regulatory Commission’s “Approval for the Registration of Shandong Linuo Special Glass Co., Ltd.’s Issuance of Convertible Corporate Bonds to Unspecified Objects” (CSRC License [2023] No. 1629), the company issued 5,000,000 convertible corporate bonds (hereinafter referred to as “Convertible Bonds”) to unspecified objects, with a face value of RMB 100.00 each, and the total amount raised was RMB 500,000,000.00. Yuan (including issuance expenses), the net amount of funds raised after deducting issuance expenses (excluding tax) was RMB 491,444,687.66.
With the approval of the Shenzhen Stock Exchange (hereinafter referred to as the "Shenzhen Stock Exchange"), the company's convertible bonds will be listed on the Shenzhen Stock Exchange on September 14, 2023. The bond abbreviation is "Lino Convertible Bonds" and the bond code is "123221". It will enter the conversion period on February 29, 2024. The initial conversion price is 14.40 yuan/share, and the latest conversion price is 14.20 yuan. Yuan/share, the adjusted conversion price will take effect from May 29, 2025.
From March 3, 2026 to March 9, 2026, a total of 1,507,223 of the company's convertible bonds "Lino Convertible Bonds" have been converted into shares, adding a total of 10,613,757 "Lino Medicine Pack" shares, and the company's total share capital increased from 256,399,814 shares to 267,013,571 shares, resulting in Linuo Investment's shareholding ratio being passively diluted from 29.99% to 28.80%, touching an integer multiple of 1%, while the number of shares held remained unchanged, and the dilution change ratio was 1.19%.
The details of this equity change are as follows:
1.Basic situation
Information disclosure obligor Linuo Investment Holding Group Co., Ltd.
Residence: No. 30766, Jingshi East Road, Jinan Area, China (Shandong) Pilot Free Trade Zone Linuo Technology Park Equity Change Time March 9, 2026
From March 3, 2026 to March 9, 2026, as a total of 1,507,223 of the company's convertible bonds "Lino Convertible Bonds" were converted into shares, a total of 10,613,757 shares of "Lino Medicine Pack" were added, and the company's total share capital increased from 256,399,814 shares to 267,013,571 shares, resulting in changes in Linuo Investment's shareholding interests.
With the number unchanged, its shareholding ratio was passively diluted from 29.99% to 28.80%, touching an integral multiple of 1%. This change in equity will not lead to changes in the company's controlling shareholders and actual controllers, nor will it affect the company's governance structure and ongoing operations.
Stock abbreviation Linuo Medicine Pack stock code 301188
Direction of change Up □ Down ☑ People acting in concert Yes □ No ☑
Is it the largest shareholder or actual controller? Yes ☑ No □
- Changes in equity this time
Type of shares Number of shares increased/decreased (10,000 shares) Increase/decrease ratio
A shares 0 Shareholding ratio passively diluted 1.19% Total 0 Shareholding ratio passively diluted 1.19%
Centralized trading through stock exchanges
Block trades through stock exchanges
Method of this equity change (multiple choices available)
Others ☑ (Passive dilution when convertible bonds are converted into shares)
- Before and after this change, investors and their persons acting in concert have shares in listed companies.
Shares held before this change. Shares held after this change.
Nature of shares
Number of shares (shares) Proportion of total share capital (%) Number of shares (shares) Proportion of total share capital (%)
Total shares held by Linuo Investment 76,895,461 29.99 76,895,461 28.80
Including: shares without sales restrictions 76,895,461 29.99 76,895,461 28.80 shares with sales restrictions 0 0 0 0 Note: The "Lino Convertible Bonds" issued by the company are in the conversion period. The shareholding ratio before this change was calculated based on the total share capital of 256,399,814 shares as of March 2, 2026. The shareholding ratio after this change was calculated based on the total share capital of 267,013,571 shares as of March 9, 2026.
- Implementation of commitments, plans, etc.
Whether this change has been made for fulfillment
commitments, intentions, plans
Yes□ No☑
Whether this change violates the "certificate"
Securities Law "Acquisition Management of Listed Companies"
Measures and other laws, administrative regulations,
Yes □ No ☑Department regulations, normative documents and this
Situations stipulated in business rules, etc.
- Shares with restricted voting rights
In accordance with Article 63 of the Securities Law
stipulations, are there any shares that cannot exercise voting rights Yes□ No☑
Further explanation on the increase in shareholdings of shareholders above 30% (not applicable)
Documents available for inspection
1． Details of changes in shareholdings of China Securities Depository and Clearing Co., Ltd. □
- Relevant written commitment documents □
3． Lawyer’s written opinion □
4． Other documents required by the Exchange
☑
2. Other related instructions
This equity change is a passive dilution and does not involve a tender offer. It will not lead to changes in the company's controlling shareholders and actual controllers, will not affect the stability of the company's control rights, and will not have an impact on the company's governance structure and ongoing operations.
This equity change does not violate the provisions of the Securities Law of the People's Republic of China, the Measures for the Administration of Acquisitions of Listed Companies and other laws, regulations and normative documents.
"Lino Convertible Bonds" are currently in the conversion period. The company will continue to pay attention to the changes in shareholders' equity and perform its information disclosure obligations in a timely manner in accordance with relevant laws and regulations.
Announcement is hereby made.
Board of Directors of Shandong Linuo Pharmaceutical Packaging Co., Ltd.
March 10, 2026